Glecaprevir/pibrentasvir: Ph III ENDURANCE-1 data

Top-line data from 351 non-cirrhotic patients with chronic HCV genotype 1 infection in the open-label, international Phase III ENDURANCE-1 trial showed

Read the full 215 word article

User Sign In